Summary & Overview
CPT 80434: Insulin Tolerance Test with Serial Glucose and Cortisol Measurements
CPT code 80434 represents a dynamic laboratory assay in which glucose and cortisol concentrations are measured across five timed blood draws—one baseline and four post-insulin samples—to evaluate physiologic response to insulin. The test is clinically used in endocrine assessment, including evaluation of adrenal and glucose regulatory function, and holds relevance for specialty care pathways in endocrinology and hospital-based diagnostic services. Nationally, this code reflects specialized diagnostic testing with implications for laboratory workflow, utilization review, and payer coverage policies.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context of the procedure, typical sites of service where the test is performed, and which payers commonly cover such specialized endocrine diagnostic laboratory services. The publication also outlines what to expect in payer coverage discussions—benchmarks on utilization and reimbursement are examined where available—and summarizes policy trends that affect laboratory services billing for dynamic endocrine testing.
The content provides clinicians, billing professionals, and policy analysts with actionable reference material on CPT code 80434, including clinical purpose, service delivery settings, and payer landscape. Data not available in the input is noted explicitly where applicable.
Billing Code Overview
CPT code 80434 describes a laboratory procedure in which a lab analyst measures glucose and cortisol levels in a series of five blood samples: one obtained before and four obtained after administration of insulin. The service is a combined glucose and cortisol dynamic insulin tolerance test that evaluates endocrine and metabolic response to insulin stimulation.
-
Service Type: Endocrine diagnostic laboratory test (insulin tolerance test with serial glucose and cortisol measurements)
-
Typical Site of Service: Hospital outpatient laboratory, clinical laboratory, or specialized endocrinology testing facility
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 45-year-old patient with suspected hypoglycemia undergoes an insulin tolerance test to evaluate counter-regulatory hormone response and glucose homeostasis. The procedure is performed in an outpatient endocrinology clinic or hospital clinical laboratory under direct physician supervision. After informed consent, baseline blood is drawn for glucose and cortisol. Short-acting insulin is administered intravenously, and timed blood samples are collected: one pre-insulin and four post-insulin draws (commonly at 30, 45, 60 and 90 minutes) for measurement of serum glucose and cortisol. The lab analyst processes and measures glucose and cortisol levels for each of the five samples. The supervising endocrinologist monitors the patient for symptomatic hypoglycemia, documents vital signs and mental status at intervals, and provides corrective glucose as needed. Results are reviewed by the clinician to assess pituitary-adrenal axis integrity and counter-regulatory hormone response, guiding diagnosis and management of adrenal insufficiency, growth hormone deficiency, or disorders of glucose regulation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician interpretation/supervision portion, separate from the technical lab processing. |
TC |